141 related articles for article (PubMed ID: 16225480)
1. HCV liver infection and liver steatosis: evidence for indirect mechanisms in genotype 3?
Grassi A; Ballardini G; Susca M; Bianchini F; Bonoli S; Bianchi FB; Lenzi M
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():79-82. PubMed ID: 16225480
[TBL] [Abstract][Full Text] [Related]
2. Liver HCV-antigens and steatosis in chronic hepatitis C: role of different genotypes.
Grassi A; Cipriano V; Quarneti C; Bianchini F; Susca M; Zauli D; Lenzi M; Bianchi G; Bianchi FB; Ballardini G
Dig Liver Dis; 2009 Sep; 41(9):659-64. PubMed ID: 19185553
[TBL] [Abstract][Full Text] [Related]
3. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response.
Kumar D; Farrell GC; Fung C; George J
Hepatology; 2002 Nov; 36(5):1266-72. PubMed ID: 12395339
[TBL] [Abstract][Full Text] [Related]
5. The relationship between serum adiponectin and steatosis in patients with chronic hepatitis C genotype-4.
Ashour E; Samy N; Sayed M; Imam A
Clin Lab; 2010; 56(3-4):103-10. PubMed ID: 20476641
[TBL] [Abstract][Full Text] [Related]
6. Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections.
Hézode C; Roudot-Thoraval F; Zafrani ES; Dhumeaux D; Pawlotsky JM
J Viral Hepat; 2004 Sep; 11(5):455-8. PubMed ID: 15357652
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus genotype 3 predominates in North and Central India and is associated with significant histopathologic liver disease.
Hissar SS; Goyal A; Kumar M; Pandey C; Suneetha PV; Sood A; Midha V; Sakhuja P; Malhotra V; Sarin SK
J Med Virol; 2006 Apr; 78(4):452-8. PubMed ID: 16482560
[TBL] [Abstract][Full Text] [Related]
8. Hepatic steatosis in HIV/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy study.
Rodríguez-Torres M; Govindarajan S; Solá R; Clumeck N; Lissen E; Pessôa M; Buggisch P; Main J; Depamphilis J; Dieterich DT
J Hepatol; 2008 May; 48(5):756-64. PubMed ID: 18314217
[TBL] [Abstract][Full Text] [Related]
9. Effect of steatosis and inflammation on liver fibrosis in chronic hepatitis C.
Nieminen U; Arkkila PE; Kärkkäinen P; Färkkilä MA
Liver Int; 2009 Feb; 29(2):153-8. PubMed ID: 18482270
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C.
Ballardini G; Groff P; Pontisso P; Giostra F; Francesconi R; Lenzi M; Zauli D; Alberti A; Bianchi FB
J Clin Invest; 1995 May; 95(5):2067-75. PubMed ID: 7738174
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C.
Wedemeyer I; Bechmann LP; Odenthal M; Jochum C; Marquitan G; Drebber U; Gerken G; Gieseler RK; Dienes HP; Canbay A
J Hepatol; 2009 Jan; 50(1):140-9. PubMed ID: 19019483
[TBL] [Abstract][Full Text] [Related]
12. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis.
Mirandola S; Realdon S; Iqbal J; Gerotto M; Dal Pero F; Bortoletto G; Marcolongo M; Vario A; Datz C; Hussain MM; Alberti A
Gastroenterology; 2006 May; 130(6):1661-9. PubMed ID: 16697730
[TBL] [Abstract][Full Text] [Related]
13. [Hepatitis C virus-associated and metabolic steatosis. Different or overlapping diseases?].
Lonardo A; Loria P; Adinolfi LE; Andreana A; Ruggiero G; Carulli N
Ann Ital Med Int; 2005; 20(1):10-22. PubMed ID: 15859390
[TBL] [Abstract][Full Text] [Related]
14. Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus.
Marks KM; Petrovic LM; Talal AH; Murray MP; Gulick RM; Glesby MJ
J Infect Dis; 2005 Dec; 192(11):1943-9. PubMed ID: 16267765
[TBL] [Abstract][Full Text] [Related]
15. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
[TBL] [Abstract][Full Text] [Related]
16. Steatosis in chronic hepatitis C: relationship to the virus and host risk factors.
Matos CA; Perez RM; Pacheco MS; Figueiredo-Mendes CG; Lopes-Neto E; Oliveira EB; Lanzoni VP; Silva AE; Ferraz ML
J Gastroenterol Hepatol; 2006 Aug; 21(8):1236-9. PubMed ID: 16872303
[TBL] [Abstract][Full Text] [Related]
17. [Hepatitis-C infection and hepatic steatosis].
Bosques-Padilla F
Gac Med Mex; 2004; 140 Suppl 2():S73-6. PubMed ID: 15641475
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
[TBL] [Abstract][Full Text] [Related]
19. Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.
Castéra L; Loko MA; Le Bail B; Coffie P; De Ledinghen V; Trimoulet P; Winnock M; Dabis F; Neau D;
Aliment Pharmacol Ther; 2007 Dec; 26(11-12):1489-98. PubMed ID: 17903235
[TBL] [Abstract][Full Text] [Related]
20. Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors.
Bani-Sadr F; Carrat F; Bedossa P; Piroth L; Cacoub P; Perronne C; Degott C; Pol S;
AIDS; 2006 Feb; 20(4):525-31. PubMed ID: 16470116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
